Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Glycyrrhetinic Acid and Acute Irritant Dermatitis [NA]

View source ↗

Summary

Clinical trial update on glycyrrhetinic acid for irritant contact dermatitis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycyrrhetinic acid (glycyrrhetinic acid)

Snippet

Sponsor: University of Split, School of Medicine | Conditions: Irritant Contact Dermatitis | NA | Status: NOT_YET_RECRUITING